Women at average risk for breast cancer face confusion regarding mammogram screening advice due to conflicting recommendations from several major health organizations in the U.S. The U.S. Preventive Services Task Force (USPSTF) recently released a draft recommendation in 2023 suggesting women begin screening at age 40, a change from its previous advice of starting at 50, and to screen every other year until age 74. This contrasts with the American Cancer Society's (ACS) guidance, which recommends annual mammograms from ages 40-44, annual screenings from 45-54, and then every other year for those 55 and older as long as they are in good health.
Other organizations, such as the American College of Physicians (ACP), suggest shared decision-making for women aged 40-49 and mammograms every one to two years for those 50-74, while the American College of Radiology (ACR) advises annual screening starting at age 40. The USPSTF's shift to age 40 was partly influenced by data indicating higher breast cancer mortality rates in Black women and earlier onset of the disease, though they concluded that annual screening did not significantly improve outcomes compared to biennial screening for women in their 40s. The article also notes potential harms of earlier screening, including false positives, unnecessary biopsies, and overdiagnosis, affecting approximately one in nine women screened over a decade.
The differing advice leaves many women unsure about the optimal age and frequency for screening. Experts like Dr. William Dahut of the ACS and Dr. Diana Ramos of the American Medical Association stress the importance of individualizing screening decisions. Patients are encouraged to discuss their personal risk factors, preferences, and the potential benefits and harms of screening with their doctor to make an informed choice.
